Drug Dev Ind Pharm, 2009 Dec;35(12):1430-8.
PMID: 19929202 DOI: 10.3109/03639040902988566

Abstract

The purpose of this study was to design a 24-hour controlled porosity osmotic pump system that utilizes polyvinyl pyrrolidone (PVP) as an osmotic-suspending/release retarding agent of drugs.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.